Pad Chivukula, Chief Scientific Officer & COO at Arcturus Therapeutics Holdings Inc. (ARCT), sold 25,000 shares at $30.24 ($752K) on 2023-05-11, disclosed to the SEC on 2023-05-12.
Scheduled sale ($752k) by Chief Scientific Officer & COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.00 | 17,075 | $512K | 68.1% |
| 2 | $30.24 | 7,925 | $240K | 31.9% |
| Total | $30.08 avg | 25,000 | $752K | 100% |
| Filing → |
| ARCT | SELL | 2024-06-04 | $1.0M | — | Filing → |
| ARCT | SELL | 2024-03-27 | $1.2M | — | Filing → |
| ARCT | SELL | 2024-03-21 | $600K | — | Filing → |